Two audiences read this page differently. For Government of Jersey and Digital Jersey policy officials, this is a checklist of infrastructure investments that need to happen — some already in flight, some new — and the specific windows in which decisions are being made. For biotech partners and healthcare investors, this is a diagnosis of what would need to be built for Jersey to actually deliver on the regulatory promise, and where the gaps sit today.
The most important thing on this page is the Overdale hospital procurement — the digital and IT stack decisions for the new hospital are being made right now, and they set the ceiling on what Jersey can do in health innovation for the next twenty years. Get that right and the rest of the infrastructure is a set of extensions and integrations; get it wrong and everything downstream fights the wrong architecture forever.
Overdale as the foundation.
Jersey's new hospital is under construction at the Overdale site, planned to open ~2029-2030. The physical build is one set of decisions; the digital and IT stack that runs it is another, and it is the one that matters most for the health-innovation framework.
The specific decisions that need to be right at Overdale procurement:
- Electronic health record (EHR) — a modern, standards-compliant EHR (Epic, Oracle Health, ORION Health, Nervecentre for smaller-jurisdiction fit, or an open-source assembly around OpenMRS / OpenEHR) versus a legacy NHS-Jersey-style extension.
- HL7 FHIR-native architecture — every clinical data flow expressed as FHIR resources from Day 1, so Overdale, private clinics (Windsor Medical Practice, private wellness and longevity providers, others), primary care, and any outcome registry can exchange data without brittle point-to-point integrations.
- Common patient identifier — an island-wide unique patient identifier that Overdale, private providers, and pharmacies can all reference, so that PGx findings recorded at any authorised private clinic actually reach the patient's GP's prescribing screen.
- Open APIs by default — third-party integration (registries, telemedicine, research platforms, patient-facing apps) permitted by design rather than blocked by architecture.
- Cloud-native + on-island data residency — modern cloud infrastructure with contractual data-residency guarantees so patient data remains under Jersey jurisdiction while the platform remains modern.
The 12-24 month window
Overdale IT procurement decisions taken in this window shape what is possible for the next twenty years. A hospital procurement that treats digital as a subsystem of a physical build — the historical NHS default — locks in an architecture that will actively obstruct the health-innovation framework. A hospital procurement that treats the digital stack as strategic infrastructure equivalent to the physical build makes the rest of this page achievable.
Concretely: the framework advocacy described in The Case should include Overdale IT specification as a Government of Jersey-owned strategic priority, with Digital Jersey chairing the digital-architecture working group alongside HCS.
Everything else that needs to sit around it.
Overdale is the anchor but not the whole picture. The health-innovation framework requires a coordinated stack of software, data, and clinical infrastructure across public and private providers, with the Health Innovation Framework Office as the coordinating spine.
1 · Clinical data interoperability
Beyond Overdale itself, every clinical provider on the island — private clinics, Windsor Medical Practice, primary-care GPs, private wellness and longevity clinics, and any future providers authorised under the framework — needs to speak the same clinical-data language. HL7 FHIR is the international standard; most modern EHRs support it natively. Legacy providers may need integration middleware or platform upgrades.
What Jersey needs
An island-wide FHIR-compliance policy (deadline for all providers to reach a defined FHIR-conformance level), a coordinated integration layer or health information exchange (HIE) hub, and a common patient-identifier scheme. Approximate one-off cost: £5-15M capex plus £1-3M/yr operating.
Already partly in flight
Digital Jersey has been working on health-data interoperability standards; some elements of a Jersey Care Record exist in early form. The framework requirement is to accelerate and formalise this work with defined deadlines and coordinated funding.
2 · Outcome-registry infrastructure
The regulatory framework mandates outcome-registry participation across almost every domain: PGT-P outcomes, MRT outcomes, psychedelic-therapy outcomes, longevity-therapeutic outcomes, MCED performance data, aesthetic-medicine harm registry, n=1 trial outcomes, and more. Each registry needs a proper platform: secure clinical-data capture, patient-consent management, longitudinal follow-up (some registries need 20+ year cohort tracking), regulator access for audit and quality assurance, and controlled research access.
What Jersey needs
A shared registry platform hosted under Jersey data residency, capable of hosting multiple domain-specific registries under a common technical + governance framework. Off-the-shelf options exist (REDCap for research-cohort registries; commercial platforms from EY Health, Optum, IQVIA, or specialist providers like Castor EDC). Approximate one-off cost: £3-10M capex plus £1-3M/yr operating covering all domains.
3 · Sovereign health-data hosting + cyber-security
Health data is the highest-value target for cyber-attacks and carries the strictest data-protection obligations. GDPR and Jersey's own Data Protection (Jersey) Law 2018 require appropriate technical + organisational measures; the framework's international-patient flows require careful international-transfer compliance (Standard Contractual Clauses, adequacy assessments, DPIAs).
What Jersey needs
A sovereign or trusted-vendor cloud region with contractual Jersey data residency for sensitive clinical data, an island-wide cyber-security posture coordinated across public and private providers (rather than each provider defending alone), a strengthened Office of the Information Commissioner with capacity for the additional volume, and standardised international-transfer templates for common patient flows. Approximate one-off cost: £5-15M capex plus £2-5M/yr operating.
Already partly in flight
Jersey has some sovereign digital-infrastructure capacity via Digital Jersey and Government of Jersey Digital Services. The gap: coordinated cyber-defence across private clinical providers, and clearer international-transfer templates for the specific patient flows the health-innovation framework generates.
4 · RegTech for the Health Innovation Framework Office
The framework itself needs its own software. A regulatory office that reviews clinical-protocol applications, issues authorisations, schedules inspections, tracks outcome-registry compliance, publishes public transparency reports, and handles appeals cannot run on spreadsheets. The JFSC has decades of experience running exactly this pattern for fund licensing — the health equivalent can borrow the pattern.
What Jersey needs
An application-and-review portal for framework authorisations (protocol submissions, hosting-scope registrations, device authorisations, practitioner accreditations), workflow engine for review-and-inspection cycles, audit-trail systems that meet JCC and JFSC standards, and a public-facing transparency layer that publishes framework outcomes without breaching patient confidentiality. Approximate one-off cost: £2-5M capex plus £0.5-1M/yr operating.
5 · Patient-facing digital layer
International patients arriving in Jersey for framework-authorised care need modern digital tools: pre-visit assessments, appointment booking across multiple providers, secure record access, telemedicine for pre + post-treatment consultation with clinicians who may be in a different jurisdiction (their home GP, an external specialist consulted for a second opinion), prescription management, and post-visit follow-up. Overdale, private clinics, and other authorised providers should share or interoperate on this rather than each building its own island.
What Jersey needs
A patient-facing digital layer (native app + web) that federates across authorised providers under a common patient identifier. Modern telemedicine platform (defined-provider or commercial: Doxy.me, Zoom Healthcare, Amwell) with GDPR/UK data flow compliance. Prescription-management integration with Jersey pharmacies. Approximate one-off cost: £3-8M capex plus £1-2M/yr operating.
6 · AI, analytics + clinical decision support
The framework will generate significant volumes of high-quality longitudinal data — genomic panels, PGx results, imaging (full-body MRI, DEXA, ultrasound), continuous metabolic monitoring, cohort outcomes across registries. That data supports both individual patient care (AI-assisted radiology reads, clinical decision support for polygenic risk interpretation) and population-scale analytics (framework-performance monitoring, real-world evidence generation, comparative effectiveness).
What Jersey needs
An analytics platform layered above the clinical-data infrastructure with controlled access for clinicians, researchers, and the Framework Office. AI/ML clinical-decision-support capability (imaging AI is the most mature — commercial partners like Aidoc, Rad AI, Annalise; genomic AI is emerging). Clear governance around AI use in clinical care (which decisions may be AI-informed vs AI-assisted vs AI-decided). Approximate one-off cost: £3-10M capex plus £1-3M/yr operating.
7 · Talent + training pipeline
None of the above runs without trained people. Jersey needs clinical informaticians, health-data engineers, GDPR-specialist data-protection officers, biostatisticians for registry analytics, cybersecurity specialists with health-data focus, and clinicians comfortable working inside a modern digital clinical environment. This is a talent pipeline decision as much as a software decision.
What Jersey needs
A structured training and recruitment programme, potentially including Highlands College curriculum development (health informatics, clinical-data engineering, health cybersecurity), partnerships with UK universities (King's Digital, Manchester Health Informatics, UCL), and structured secondment paths from JFSC to a future Framework Office for people with the closest relevant skill set. Cost mostly absorbed into existing training + recruitment budgets with modest additional programme investment (£1-3M capex + £0.5-1M/yr).
Physical facilities + specialist personnel.
The digital + data stack above is one half of what needs to be built. The other half is physical: specialist clinical facilities and specialist people that do not exist on the island today and cannot be procured off the shelf. Jersey has no IVF laboratory, no embryologist, no on-island genomics sequencing capacity, no clinical geneticist, no dedicated whole-body preventive MRI scanner, no MHRA-standard sterile compounding pharmacy, no cell + tissue processing lab. Each of these is a discrete build-and-recruit project — small compared to the Overdale hospital envelope but each critical to a specific set of framework domains.
1 · IVF + embryology lab
Reproductive-medicine domain — Jersey currently has no IVF laboratory. Every element of Domain 01 (sex-selection IVF, elective egg + embryo freezing, MRT, PGT-M/A/P) depends on an on-island lab plus a resident embryologist. Today, any Jersey resident wanting IVF travels to the UK. Any framework-authorised reproductive-medicine service requires this facility to exist.
What Jersey needs
A modest-scale IVF laboratory (Class II biosafety cabinet workstations, incubators, cryostorage tanks, micromanipulation station for ICSI + PGT biopsy, embryology-suite fit-out to HFEA-equivalent standards). Plus a full-time or lead embryologist (there are approximately 500 registered embryologists in the UK; recruitment to Jersey needs an island-recruitment premium and quality-of-life sell). Approximate cost: £500k-£1.5M capex for the lab; £400-800k/yr operating (embryologist + supporting technician + consumables + maintenance).
2 · Genomics + molecular pathology lab
Diagnostics + reproductive-medicine domains — Jersey currently has no on-island whole-genome sequencing capacity. Samples for WGS, PGx panels, PGT biopsies, and MCED tests are shipped to UK or US reference labs, adding 2-4 weeks turnaround and complicating any framework outcome-registry integration. No clinical geneticist practises on the island (there is a small handful of genetic counsellors accessible via UK video links).
What Jersey needs
A phased build: start with a sample-hub facility (proper handling, chain of custody, reference-lab partnerships with UK / EU / US labs) at approximately £200-500k capex + £150-300k/yr operating. Move to on-island short-read sequencing capacity (Illumina NextSeq class) once volumes justify at approximately £2-4M capex + £600k-1.2M/yr operating. Recruit a clinical geneticist (approximate cost £120-180k base + island premium) and 1-2 genetic counsellors (£60-90k each).
3 · Whole-body MRI + advanced imaging
Diagnostics domain — Jersey General Hospital has diagnostic MRI capacity, but there is no dedicated whole-body preventive-screening scanner or protocol on the island. Prenuvo-equivalent full-body screening — a headline element of the diagnostics framework — currently is not deliverable in Jersey. Subspecialty radiologists trained in preventive-screening MRI interpretation (a distinct skill set from diagnostic radiology) do not practise on the island in any volume.
What Jersey needs
A 3T open-bore MRI scanner configured for whole-body preventive-screening protocols, sited either at Overdale (shared use, with dedicated preventive-screening sessions) or at a private-provider facility. Approximate cost: £1.5-3M capex + £300-500k/yr operating (technologist, maintenance, quality assurance). Recruitment of 1-2 subspecialty radiologists with preventive-screening + molecular-imaging expertise (£120-180k base + island premium); alternatively contracted-review model with UK or US specialist reads at higher unit cost but no recruitment risk.
4 · MHRA-standard sterile compounding pharmacy
Longevity + advanced-therapeutics + trials domains — Jersey pharmacies undertake limited compounding but there is no facility meeting MHRA "Specials" or equivalent standards for sterile compounding of injectable peptides, IV therapeutics, novel formulations, and small-batch investigational-product preparation. The framework's authorised peptide + GLP-1 + NAD+ + clinical-trial IP supply all depend on this capacity.
What Jersey needs
A Class C clean-room facility with laminar-flow cabinets, quality-control lab, and MHRA-equivalent GMP-compliant processes. Recruit a compounding pharmacist with sterile-compounding specialism (approximately £70-100k base + premium; the specialism is scarce). Approximate cost: £300k-£800k capex + £150-300k/yr operating.
5 · Cell + tissue processing lab
Advanced-therapeutics + regenerative-aesthetics domains — Stem-cell and exosome research trials, PRP processing at pharmaceutical-grade standard, and biobank sample handling all require a properly-specified processing facility. Jersey has none currently.
What Jersey needs
A Class C-D clean-room processing lab with cell-culture equipment, cryostorage, quality-control capacity, and appropriate biosafety and radiation-monitoring where indicated. Cell + tissue processing scientist (approximately £60-90k). Approximate cost: £500k-£1.5M capex + £200-400k/yr operating.
6 · Clinical-trial support infrastructure
Trials + advanced-therapeutics domains — GCP-trained clinical research coordinators, GCP-compliant investigational-product storage (refrigerated + controlled-drug secure), a biobank facility with proper sample-handling and long-term storage, monitoring space for external CRO or sponsor visits. None of these exist in Jersey at framework scale today.
What Jersey needs
Recruitment or training of 2-4 GCP-trained clinical research coordinators (£45-70k each), GCP-compliant IP storage build-out (£100-200k), biobank facility with -80°C + vapour-phase liquid-nitrogen storage plus sample tracking software (£150-300k). Approximate total: £200-500k capex + £150-300k/yr operating.
7 · Psychedelic-therapy facility + trained workforce
Psychedelic-therapeutics domain — Ketamine treatment and psilocybin and MDMA research programmes each require dedicated dosing environments (comfortable, quiet, dual-therapist workspace with monitoring capacity and adjacent recovery). Trained-therapist workforce does not exist on the island; UK training pathways are not yet formalised because psychedelic therapy is not licensed in the UK.
What Jersey needs
Dedicated dosing rooms fitted out to appropriate spec (typically £50-100k per room, 2-4 rooms initially). A formal training programme for psychedelic-assisted therapists (route: partnership with Oregon Compassion Center licensees, MAPS / Lykos, or Australian TGA-approved trainers). Initial cohort of 4-8 trained therapists at £50-80k each. Approximate cost: £200-500k capex + £200-400k/yr operating including trainee-therapist salaries.
8 · Specialist personnel who do not currently practise in Jersey
Across the seven regulatory domains, a specific set of specialist clinical roles either does not exist on the island today or exists in single-digit numbers insufficient to support the framework at operational scale:
- Embryologist — none on-island
- Clinical geneticist — none on-island
- Genetic counsellors — limited access via UK video links
- Reproductive-medicine consultant — none on-island
- Molecular pathologist — none on-island
- Subspecialty radiologists (preventive imaging, molecular imaging) — none on-island
- Sterile-compounding pharmacist — none on-island
- Cell + tissue processing scientist — none on-island
- Trained psychedelic-assisted therapists — none on-island
- GCP-trained clinical research coordinators — very limited
- Radiation Protection Adviser (RPA) — retained via UK contract
Recruiting each of these roles to Jersey requires an island-recruitment premium (typically 15-25% above UK base salary) plus relocation support, housing assistance for the first year, and family-integration support. Aggregate personnel-recruitment premium above baseline UK salaries: approximately £500k-£1.5M/yr at framework maturity, sitting alongside the base salary costs absorbed into operating budgets for each facility above.
None of these facilities is expensive in absolute terms (compared with the Overdale hospital envelope, each of them sits inside a single-digit percentage figure). But every one of them requires a specific procurement, a specific fit-out timeline, a specific recruitment programme, and a specific set of clinical governance decisions. They cannot be built retrospectively once framework demand appears; they need to exist so framework demand has somewhere to land.
Infrastructure spend across the framework stack.
Excluding the Overdale hospital capex itself (which is happening regardless of the framework), the additional infrastructure spend to make the health-innovation framework operational — covering both the digital + data stack and the physical facilities + specialist personnel — sits in the low-to-mid tens of millions capex plus mid-single-digit millions per year in operating cost. Illustrative:
| Stack element | One-off capex | Annual operating |
|---|---|---|
| Digital + data stack | ||
| Overdale IT specification uplift (framework-ready EHR + FHIR-native architecture) | £10-25M | Absorbed in Overdale opex |
| Clinical data interoperability (island-wide FHIR + HIE hub + common patient ID) | £5-15M | £1-3M |
| Outcome-registry platform (multi-domain) | £3-10M | £1-3M |
| Sovereign data hosting + cyber-security | £5-15M | £2-5M |
| RegTech for Framework Office | £2-5M | £0.5-1M |
| Patient-facing digital layer | £3-8M | £1-2M |
| AI + analytics platform | £3-10M | £1-3M |
| Talent + training pipeline (digital) | £1-3M | £0.5-1M |
| Physical facilities + specialist personnel | ||
| IVF + embryology lab (equipment + fit-out + embryologist) | £0.5-1.5M | £0.4-0.8M |
| Genomics + molecular pathology lab (phased: sample-hub → on-island sequencing) | £0.2-4M | £0.2-1.2M |
| Whole-body MRI + advanced imaging (3T scanner + preventive-screening protocols) | £1.5-3M | £0.3-0.5M |
| MHRA-standard sterile compounding pharmacy | £0.3-0.8M | £0.15-0.3M |
| Cell + tissue processing lab (clean-room + cryostorage) | £0.5-1.5M | £0.2-0.4M |
| Clinical-trial support infrastructure (IP storage + biobank + CRC recruitment) | £0.2-0.5M | £0.15-0.3M |
| Psychedelic-therapy facility + trained therapist workforce | £0.2-0.5M | £0.2-0.4M |
| Specialist-personnel recruitment premium (above UK-baseline salaries) | — | £0.5-1.5M |
| Aggregate infrastructure envelope (digital + physical) | £35-104M | £8.5-22M/yr |
Set against the £450M-£1.7B/year aggregate economic impact on the Economic Impact page, this infrastructure spend is one-off capex of roughly 2-25% of a single year of mature framework contribution — well under one year’s value even at the low end. The economics are straightforward; the timing is what matters.
Who pays for what.
The stack above is a coordinated whole but the funding sources for each element differ. A workable funding split:
- Overdale IT uplift — funded within the existing Overdale capital envelope, with the uplift justified as protection of a twenty-year infrastructure decision. Government of Jersey.
- Clinical data interoperability + sovereign hosting + cyber-security — Government of Jersey capital investment, coordinated by Digital Jersey and Government of Jersey Digital Services. Framework advocacy needs to secure the funding case.
- Outcome-registry platform + RegTech — funded by the Framework Office directly, with authorisation-and-registry fees from framework participants covering ongoing operating costs (JFSC model).
- Patient-facing digital + AI/analytics — mix of provider investment (private clinics co-investing on the patient-facing layer) and Government of Jersey investment (analytics platform serving both public and private).
- IVF + embryology lab, genomics lab, cell processing lab, sterile compounding pharmacy — most naturally funded by private-provider investment against future service revenue, potentially with Government of Jersey seed-capital or loan-guarantee support to bridge the pre-revenue period.
- Whole-body MRI + advanced imaging — either Overdale shared-use with dedicated preventive-screening sessions (Government of Jersey capex), or a private-provider facility (private capex), or a shared-service model between the two.
- Clinical-trial support infrastructure — funded initially by partner biotech pre-payments against future hosting, with the Framework Office coordinating shared elements (biobank, IP storage) across multiple partners.
- Psychedelic-therapy facility + training — private-provider capex with framework-authorisation dependency (facility cannot recover cost until psychedelic-therapy framework legislation passes).
- Specialist-personnel recruitment premium — absorbed into per-facility operating budgets; Government of Jersey could coordinate an island-recruitment support programme (housing, relocation, spouse-career support) to reduce per-role premium.
- Talent + training pipeline — Highlands College curriculum + Government of Jersey training budget + provider-funded on-the-job training.
The total public capex ask across the framework infrastructure — realistically £25-60M over 5-7 years, with an additional £5-15M in private-provider facility capex — is meaningfully smaller than the direct healthcare-framework revenue the mature framework returns to the island each year. Framework revenue can subsequently subsidise infrastructure operating costs via the fee-based model the JFSC operates today.
What needs to happen first.
Not all of this happens at once. The sequencing that matters:
- Now — Overdale IT procurement decisions. The most consequential and time-sensitive decision on this page. If Overdale procures a legacy stack, everything downstream fights that architecture for two decades.
- Now-Y1 — Specialist-personnel recruitment programme. Embryologist, clinical geneticist, subspecialty radiologists, sterile-compounding pharmacist all take 6-18 months to recruit given the small candidate pools. Start immediately.
- Y1-Y2 — Interoperability policy + common patient ID. The foundation everything else builds on. Feasible under existing Digital Jersey remit.
- Y1-Y3 — IVF + embryology lab, genomics sample-hub, sterile compounding pharmacy. Sequenced so each facility is operational by the time framework legislation authorises the first services it enables.
- Y2-Y3 — Registry platform live. Needed before the first framework-authorised interventions can generate the outcome data the framework depends on.
- Y2-Y4 — Framework Office RegTech. Needed as the Framework Office begins authorising the first framework activities.
- Y3-Y5 — Whole-body MRI + advanced imaging, cell + tissue processing lab, patient-facing digital + telemedicine + prescription integration. Matures alongside framework maturity.
- Y3-Y6 — AI + analytics platform, psychedelic-therapy facility + trained-therapist cohort. Value + demand both grow with framework maturity; can start smaller and scale.
- Ongoing — Talent + training pipeline. Continuous from Y1.
The single point of highest leverage is the Overdale IT specification. Everything else is expensive but recoverable if handled thoughtfully in year one or two. Overdale is not — a procurement locked in for twenty years shapes the possibility set for a generation. The specialist-personnel recruitment programme is the second-highest leverage point: candidate pools for embryologists, clinical geneticists, and sterile-compounding pharmacists are small, and framework services cannot open without these people in place.